Core Laboratories price target raised to $19 from $18 at Piper Sandler

Piper Sandler raised the firm’s price target on Core Laboratories to $19 from $18 and keeps a Neutral rating on the shares. The debate still remains on how much U.S. land activity will decline and what this will do to pricing and margins, the analyst tells investors. Even if North America will be better than current market expectations, it is "hard to disprove the negative thesis" at the moment, Stifel says.